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The B6.Cg-Tg(Thy1-YFP)16Jrs/J transgenic mouse strain, widely used to study neuronal development and
regeneration, expresses the yellow fluorescent protein (YFP) in the peripheral nerves and the central nervous
system under the control of regulatory sequences of the Thy1 gene. The Thy1 (CD90) cell surface
glycoprotein is present on many cell types besides neurons, and is known to be involved in cell adhesion,
migration and signal transduction. We hypothesized that Thy1-activating conditions could probably
activate the truncated Thy1 regulatory sequences used in the Thy1-YFP construct, resulting in YFP
transgene expression outside the nervous system. We demonstrated that the stroma of subcutaneous
tumours induced by the injection of 4T1 or MC26 carcinoma cells into BALB/c(Thy1-YFP) mice, carrying
the same construct, indeed expressed the YFP transgene. In the tumour mass, the yellow-green fluorescent
stromal cells were clearly distinguishable from 4T1 carcinoma cells stably transfected with red fluorescent
protein. Local inflammation induced by subcutaneous injection of complete Freund’s adjuvant, as well as
the experimental wound-healing milieu, also triggered YFP fluorescence in both the BALB/c(Thy1-YFP)
and B6.Cg-Tg(Thy1-YFP)16Jrs/J mice, pointing to eventual overlapping pathways of wound-healing,
inflammation and tumour growth.
T
he cell surface glycoprotein Thy1 (CD90) is expressed on many mammalian cell types, including neurons,
thymocytes, T cells, endothelial cells and fibroblasts. It also serves as a humanmesenchymal stem cell (MSC)
marker. Its expression pattern is controlled by different promoter and enhancer elements and exhibits
tissue-, developmental stage- and species-specific differences. Thy1 has several cellular functions, including
the promotion of T cell activation and the inhibition of neurite outgrowth. It also functions as a cell adhesion
molecule, has roles in leukocyte interaction with the vascular endothelium, and in fibroblast and melanoma cell
migration, and is involved in apoptotic signalling, tumour suppression, fibroblast proliferation and lipofibroblast
development1. Regulatory sequences responsible for the neuronal expression of the Thy1 gene have been used to
establish different transgenic mouse strains to direct the transgene expression only to neuronal cells. Neurons in
the central and the peripheral nervous systems were fluorescently labelled in this way, and the developmental
effects of different growth factors and cytokines have been examined under the control of these elements2–4. The
JAX transgenic mouse strain B6.Cg-Tg(Thy1-YFP)16Jrs/J (http://jaxmice.jax.org/) expresses the fluorescent YFP
protein in the motor and sensory neurons and in subsets of the central neurons, and is widely used to study
neuronal development and regeneration5–9. In this model, the YFP transgene expression is directed by regulatory
elements from the 59 portion of the Thy1 gene, extending from the promoter to the intron following exon 4. Exon
3 and its flanking introns, known to be required for expression in non-neural cells, were deleted10. It was reported
that no YFP fluorescent signal was detected outside of the nervous system in these transgenic mice, but Thy1-
activating conditions have not been systematically studied in non-neuronal cells.
Among others, the Thy1 protein is known to be an activation-associated, inducible cell adhesion molecule on
human endothelial cells. It is upregulated in human prostate cancer stroma, and could serve as a tumour
prognostic marker11. Thy1 has also been shown to influence fibroblast adhesion and migration. Moreover,
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fibroblast and stem cell activation are important not only in inflam-
mation and wound-healing, but through their contribution to the
tumour stroma formation, they also play a role in tumour progres-
sion. We hypothesized that the YFP marker gene expression may
additionally occur in cells where Thy1 gene activation otherwise
occurs. To examine this hypothesis, we have started to test this trans-
genic mouse strain in tumourigenesis, wound-healing and inflam-
mation studies.
Results
The analysis of the transgenic mice under fluorescent microscope
revealed, as expected, the expression of the transgene was restricted
to the brain and the nerves; no other tissues proved to be fluorescent,
either on in vivo microscopic observation, or in tissue sections. Due
to their thin skin and lack of hair, the newborn mice were especially
useful for excluding the non-neuronal expression of the transgene.
Moreover, no YFP fluorescence was detected in an adipose-
derived mesenchymal stem cell culture established by standard pro-
tocols from the visceral and subcutaneous fat of adult mice
(Supplementary Figure S1).
The effect of tumour growth was tested in BALB/c(Thy1-YFP)
mice created by back-crossing the original B6.Cg-Tg(Thy1-
YFP)16Jrs/J mouse strain to BALB/c genetic background. Two
tumour cell lines were tested, the 4T1 mammary carcinoma and
the MC26 colon carcinoma, respectively. In the case of s.c. tumour
injections in the ear pinnae, in the first few days the injection site was
surrounded by a yellow fluorescent ‘‘halo’’ of cells. From about day 5,
amore circumscribed fluorescence was strongly co-localizedwith the
tumour mass. The 4T1 and the MC26 tumours behaved similarly in
this respect. YFP expression was detected at an unchanged intensity
up to the termination of the experiments, i.e. for at least 35 days
(Figure 1). Surprisingly, no YFP fluorescence was detected in the
case of metastases of the lung, kidney or peritoneum, probably as
an indication of tissue-specific differences in the expression pattern
even for the truncated Thy1 gene. For visual partitioning of the
tumour cells from the stroma, we established a red fluorescent 4T1
cell line, stably transfected with pEF1a-tdTomato plasmid (Tsien
Lab). We injected these cells s.c. into the ears of mice and, before
the tumour could cause any considerable discomfort, the mice were
sacrificed. Frozen sections from the tumour area were then examined
by fluorescent microscopy. The red tumour cells were clearly distin-
guishable from the yellow-green tumour matrix, suggesting that the
fluorescence-based cell sorting of tumour- derived stromal cells for
functional studies, including adoptive transfer experiments, or in
vivo analyses of tumour stroma formation, would be possible.
Importantly this model also could be used for the in vivo imaging
of a wide array of non-genetically labelled tumours in immunocom-
petent or immunodeficient transgenic mice (Figure 2).
To see if the activation of the Thy1 promoter might occur outside
of the tumour microenvironment, we tested inflammatory tissue, as
well. We induced local inflammation in both B6.Cg-Tg(Thy1-
YFP)16Jrs/J and BALB/c(Thy1-YFP) mice with a s.c. injection of
complete Freund’s adjuvant. In contrast with the tumour experi-
ments the inflamed tissue displayed a homogeneous, well circum-
scribed YFP fluorescence starting from day 2, which indicates that
MSC migration and/or fibroblast activation (involving Thy1 activa-
tion) might be part of the Freund’s adjuvant induced inflammation
as well (Figure 3). The fluorescence intensity of the YFP transgene
wasmuch above the autofluorescence of non-transgenic mice receiv-
ing the same treatment (Supplementary Figure 2).
Vascular endothelial cells in the vicinity of carcinomas also
seemed to demonstrate intense YFP fluorescence, which means that
these tumour cells could trigger Thy1 expression (Figure 1.D). Thy1
on activated microvascular endothelial cells is known to promote
melanoma cell migration through blood and lymphatic vessels,
and other type of tumour cells could probably also use this metastatic
route.
In response to tissue injury, and during the subsequent wound-
healing process, sequential and overlapping events take place. First,
the active bleedingmust be stopped, then inflammatory, proliferative
and tissue remodelling phases occur, which include the activation
and migration of distinct sets of immune cells, stem cells, fibroblasts
and keratinocytes. Since Thy1 is known to affect cell migration into
the wound area, we followed the changes in YFP fluorescence during
the healing process. One day after sharp superficial cuts weremade in
the ear of either B6.Cg-Tg(Thy1-YFP)16Jrs/J or BALB/c(Thy1-YFP)
mice by scalpel in anesthesia, a faint fluorescent halo appeared along
the wound, which expanded until day 14. At the end of day 3, a more
intense fluorescent margin also emerged around the wound, which
remained significantly brighter until the end of the experiment. The
fluorescence area around the wound gradually decreased from day
21, and had almost entirely disappeared by the end of day 36
(Figure 4). As in the case of the local inflammation model, the fluor-
escence intensity of the YFP transgene was much above the auto-
fluorescence of non-transgenic mice receiving the same treatment
(Supplementary Figure 2).
Discussion
Thy1 is a glycosylphosphatidylinositol (GPI)-anchored, cell surface
glycoprotein, which belongs to the immunoglobulin superfamily.
Thy1 functions as a cell adhesion molecule, and is involved in cell-
cell and cell-extracellular matrix interactions. Its occurrence on
many cell types suggests the possibility of different physiological
roles, which depend on the surrounding tissues and circumstances.
Thy1 was first discovered as a thymocyte differentiation marker
antigen12–14. It mediates thymocyte adhesion to the thymic epithe-
lium, and regulates T cell activation15. It is also important in the
adhesion of leukocytes and monocytes to endothelial cells and fibro-
blasts, and it is upregulated on the surface of activated endothelial
cells. Neuronal Thy1 induces astrocyte adhesion through avb3 integ-
rin in a cooperative interaction with the proteoglycan syndecan-416.
Thy1 participates in several signalling cascades, including signalling
via integrins, cytokins, growth factors, and tyrosine kinases, such as
focal adhesion kinase17. There are pronounced differences in the
focal adhesion structure, stress fiber and cytoskeleton arrangement
between Thy1(1) and Thy1(2) lung fibroblast populations, which
correlates with their migration capacity. Thy1(1) fibroblasts have
well developed focal adhesions and actin stress fibers andmigrate less
efficiently than Thy1(2) fibroblasts, which harbor only smaller focal
complexes and fewer stress fibers18. Leukocytes and melanoma cells
also attach via integrins to the Thy1 adhesion molecule on activated
endothelial cells. The strong induction of Thy1 on blood and lymph-
atic vessels in melanoma is induced by vascular endothelial growth
factor (VEGF) and TNF-a. Moreover, the number of melanoma
metastasis from primary subcutaneous tumour was greatly reduced
in Thy1(-/-) mice, suggesting a significant role of the Thy1 mediated
attachment of melanoma cells to microvascular EC during their
migration19.
In our experiments, the tumour stroma of primary s.c. carcinomas
also expressed the YFP transgene, as a marker of Thy1 promoter
activation. Tumours are thought to develop stroma from several
sources: the recruitment of resident tissue stem cells, the epithelial
to mesenchymal transition of the tumour parenchyma, fibroblast
recruitment into the tumour stroma, and the recruitment of bone
marrow-derived cells from the circulation20. Tumour cells interact
with their microenvironment by producing different hormones,
cytokines and chemokines. The induction of an elevated cell surface
expression of Thy1 on stromal cells could be important in the tumour
promoting remodelling of the surrounding cells, but there could be
tissue-specific differences, because the lung, liver and kidney meta-
stases derived from primary subcutaneous carcinoma, didn’t show
www.nature.com/scientificreports
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any elevated YFP transgene expression. As a model for visualizing
subcutaneous tumours in vivo, mice carrying the Thy1-YFP trans-
gene have obvious advantages. Depending on the genetic back-
ground, these mice might be used as a tool for visualizing the
growth of non-genetically modified transplantable syngeneic
tumours. After back-crossing on an immunodeficient, nude, SCID
or RAG-/- genetic background, this strain might also be used for the
visualization of xenogeneic tumours, which are widely used in the
preclinical testing of anti-tumour drugs. In comparison with the
genetic labelling of individual tumour cell lines, the advantages of
this model are evident. No genetic manipulation is needed for the
preparation of the tumour transplant, and genetic changes are there-
Figure 1 | Thy1 promoter activation in subcutaneous tumors in Thy1-YFP transgenic mice. BALB/c mice carrying the YFP transgene driven by the
regulatory elements of the Thy1 gene were injectedwith 4T1mammary carcinoma orMC26 colon carcinoma cells s.c. in the ear pinna. Photographs of the
ears were made under light anaesthesia, using a Nikon Eclipse E600 fluorescent microscope (A–F): 203 magnification objective lens, (G–K): 103
magnification objective lens). (A,B): uninjected control transmitted light and fluorescent microscopic image (C,D): transmitted light and fluorescent
microscopic image of the Thy1-YFP mice ear 7 days after 4T1 injection. A diffuse halo of YFP fluorescent cells formed around the 4T1 tumor. (E,F):
transmitted light and fluorescent microscopic image of the Thy1-YFP mice ear 14 days after 4T1 injection; the YFP fluorescence was strictly localized
within the 4T1 tumormass. (G,H): transmitted light and fluorescentmicroscopic image of the Thy1-YFPmice ear 3 days afterMC26 colon carcinoma cell
injection. (I,J): transmitted light and fluorescentmicroscopic image of the Thy1-YFPmouse ear 7 days afterMC26 injection. (K): fluorescentmicroscopic
image of the Thy1-YFP mice ear 7 days after MC26 injection. Multiple images were combined to depict the whole ear. The same phenomenon was
observed in the case of MC26 injection. Because of the intensity of the YFP fluorescence induced, the ears of tumour-bearing non-transgenic mice
appeared almost completely dark in images shot with the same settings.
www.nature.com/scientificreports
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fore avoided, e.g. those caused by the integration of the transgene into
the host chromosomes, induced during the introduction of the trans-
gene. It also prevents the ‘‘genetic drift’’ resulting from the selection
and cloning of transfectants with established transgene expression. A
further advantage of this model is the stability of the fluorescent
signal. It is well known that transfected tumour cells are genetically
unstable, and can lose or down-regulate the transgene. In contrast, in
this case, the Thy1 transgene is expressed by genetically stable, dip-
loid somatic cells, which do not tend to eliminate the marker gene.
Thy1-YFP transgenic mice could be promising tools for studying
MSC biology. It might be used to visualize tumour matrix MSC
recruitment or in situ activation. In mice, unlike in humans, Thy1
is absent on cultured, non-activated MSC. The differences in the
tissue-specific expression of Thy1 in the case of subcutaneous and
internal organ metastases might also serve as a starting point of
further studies. Additionally, the immunofluorescent FACS sorting
of dissociated tissue samples would yield pure populations of tumour
MSCs for in vitro or in vivo adoptive transfer experiments. It might
also be used for the visualization, or possibly the objective quantifica-
tion of inflammatory reactions, adaptable for both basic research and
preclinical pharmacology.
Microvascular EC does not express Thy1 in healthy adult tissue,
but it does so at the sites of inflammation or in tumours, and this can
be followed by YFP expression in these transgenic mice. Activated
Figure 2 | Examination of the tumor cell and Thy1 promoter activity co-localization. (A–C): Transmitted light, pseudo-green and red fluorescent
microscopic image of the tumor formed 35 days after 4T1-red tumor cell injection into the ear pinna of BALB/c(Thy1-YFP) transgenicmice. Photographs
of themice ears weremade under light anaesthesia, using aNikon Eclipse E600 fluorescentmicroscope. The YFP fluorescence in BALB/c(Thy1-YFP)mice
shows co-localizationwith the red fluorescence of RFP-expressing tumor cells (43magnification objective lens). (D–G): Transmitted light (F), green (D),
red (E) fluorescent and combined (G) microscopic image of the sections of the Thy1-YFP mice ear 7 days after tdTomato expressing 4T1 tumor cell
injection into the ear pinna. The red fluorescence of tumor cells is only partly co-localized with YFP fluorescence revealing the different origins of the cells
comprising the tumor body. Photographs of the sections were made using a Zeiss Axiovision Z1 fluorescent microscope (203magnification objective
lens).
www.nature.com/scientificreports
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Figure 3 | Inflammation activates the Thy1 promoter in Thy1-YFP mice. BALB/c(Thy1-YFP) transgenic mice were subcutaneously injected in the ear
pinnae with complete Freund’s adjuvant. The inflamed tissue showed a diffuse pseudo-green fluorescence. The photos illustrate the ears of two individual
mice 5 days after the injections. Photographs of the mouse ears were made under light anaesthesia, using a Nikon Eclipse E600 fluorescent microscope
(103 magnification objective lens).
Figure 4 | Wound healing activates the Thy-1 promoter in Thy1-YFP mice. The ear pinnae of BALB/c(Thy-1-YFP) mice were cut with a scalpel under
aseptic conditions, under anaesthesia, and thewound healingwas then followed by fluorescentmicroscopy. Thewound-healing process was accompanied
by temporary upregulation of the YFP fluorescence, gradually fading after 2 weeks. Photographs of the mouse ears were made under light anaesthesia,
using a Nikon Eclipse E600 fluorescent microscope (either 203magnification objective lens or 103magnification objective lens). Some of the pictures
were generated by the combination of multiple images to depict the whole wound surface.
www.nature.com/scientificreports
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microvascular endothelial cells in the vicinity of the primary carcin-
oma presented really high expression of YFP in our experiments, as a
marker of the activation of the Thy1 gene. This suggests the existence
of interacting signals between the carcinoma and endothelial cells that
can facilitate their metastatic behaviour, similarly as for melanoma
cells19. As the Thy1 protein may show up on activated microvascular
EC, this mouse strain can also be used in angiogenesis studies.
Following a tissue injury, cellular debris and potential infective
agents must be removed by a distinct set of immune cells, such as
neutrophils, macrophages, and mast cells. Fibroblasts and mesench-
ymal stem cells then enter to the wound site, and the fibroblasts
become activated and differentiate into myofibroblasts. The newly
differentiated myofibroblasts contract the wound area, and produce
extracellular matrix proteins21. It has been shown that myofibroblast
differentiation requires Thy1 expression, and impaired wound-heal-
ing was detected in Thy1(-/-) mice, and temporally blocking Thy1 in
skin wound regions worsens the quality of healing22,23. Moreover, only
Thy1(1) human myometrial and orbital fibroblasts were capable of
myofibroblast differentiation24. In contrast, Thy1 promotes the
development of lipofibroblasts, and not myofibroblasts in the mouse
lung25–27. The well circumscribed fluorescent margin around the heal-
ing area probably comprises mainly myofibroblasts and MSCs, but
migrating keratinocytes, immune cells and microvascular epithelial
cells may also be present28,29. We therefore propose the B6.Cg-
Tg(Thy1-YFP)16Jrs/J mice, or the same Thy1-YFP transgene car-
rying mouse strains as a model in wound- healing studies, where
impaired healing or the therapeutic effects of various pharmacological
agents could be investigated. Further these results also support the
view of authors who regard tumours as ‘‘over-healing’’ wounds30.
It seems that an elevated cell surface expression of Thy1 contri-
butes to cell-cell interactions, where migrating cells have to be
attached to their target, such as different immune cells at the site
of inflammation, or fibroblasts and stem cells in the wound area.
Thy1 then serves as a receptor for other cell surface proteins on
adjacent or ‘‘trapped’’ migrating cells, and could also initiate signal-
ling events itself. Moreover, Thy1 facilitates the metastasis of certain
tumour cells through activated microvascular EC. We could track
this elevated expression by following the higher fluorescent signal of
YFP. Since YFP expression is not controlled by all of the regulatory
elements of the wild type Thy1 gene, and exon 3 and its flanking
introns (known to be responsible for Thy1 expression in non-neural
cells) were deleted, the promoter and the remaining intragenic reg-
ulatory sequences could still direct higher YFP expression in some
non-neural cells, as a response to activating signals. This could be
especially interesting in studies of different tumours, where the high
diversity of the tumour and stromal cells and the surrounding tissue
could also affect tumour development and its metastatic capabilities.
Impaired wound healing could also be followed through the different
expression of the YFP marker gene, because some of the immune
cells, keratinocytes, activated fibroblasts and stem cells respond to
injury with an elevated expression of Thy1 gene.
As the Thy1 cell surface glycoprotein affects adhesion, signalling
and motility in many cell types, and its elevated expression was
demonstrated at the site of inflammation, in the formation of the
tumour stroma, and during tissue remodelling in the case of injury,
the elevated expression of the YFP transgene could serve as a fluor-
escent marker that follows these events. We plan further studies to
dissect the activation parameters of the Thy1-YFP transgene, as well
detailed analysis of the cell types expressing it. In conclusion, we
propose that these mouse strains could also be used as an inflam-
mation, wound-healing and tumour model, over and above its well
exploited potential in neuronal development studies.
Methods
Animals. The JAXmouse strain B6.Cg-Tg(Thy1-YFP)16Jrs/J was obtained from The
Jackson Laboratory. The mice were kept in a conventional animal house. Originally
the transgene was present on the heavily pigmented B6 mouse strain genetic
background. To facilitate the in vivo observation of the YFP fluorescence, transgenic
mice were back-crossed on non-pigmented BALB/c for at least 6 generations. The
BALB/c mice were obtained from Charles River Hungary. The presence of the
transgene in the back-crossed generations was visually verified by in vivo fluorescent
microscopy of the newborn mice by a long-working-distance stereo microscope,
making genetic testing unnecessary. To obtain a homogeneous fluorescence level, all
the experimental mice were hemizygous for the transgene.
Ethics.All experimental protocol were performed in accordance with national (1998.
XXVIII; 40/2013) and European (2010/63/EU) animal ethics guidelines. The were
approved by the Animal Experimentation and Ethics Committee of the Biological
Research Centre of the Hungarian Academy of Sciences and the Hungarian National
Animal Experimentation and Ethics Board (clearance numbers: XVI./03047-1/2008;
SI/01/1489-5/2014.)
Cell cultures. The 4T1 mouse mammary carcinoma cell line was obtained from
ATCC and kept in RPMI 1640 tissue culture medium supplemented with 10% FCS
(Lonza, Basel, Switzerland), and 1 mM pyruvate (Sigma, St. Louis, USA). Red
fluorescent clones were established after the transfection of 4T1 cells with pEF1a-
tdTomato plasmid (a kind gift of the Tsien Lab), and then selected on 400 mg/ml
G418 (Sigma, St. Louis, USA) containing medium. The MC26 BALB/c colon
carcinoma cell line was originally obtained from the National Institute of
Radioprotection and Radiobiology, Hungary, and kept in RPMI 1640 tissue culture
medium supplemented with 10% FCS and 1 mM pyruvate.
In vivo tumourigenesis, inflammation and wound healing. 4T1 cells were injected
subcutaneously (s.c.) either in the mammary fat pad of the flank, or s.c. into the ear
pinna of the BALB/c(Thy1-YFP) or BALB/c mice. The orthotopically growing 4T1
tumour line forms metastases in the lung, while other organs are mostly metastasis-
free. To obtain mice with metastases in other organs, in some of the experiments the
mice were injected intravenously with 105 4T1 tumour cells. In these cases, the
numerous lung metastases were accompanied by liver, kidney and, rarely, heart
metastases. MC26 cells were injected s.c. into the ear pinna. The tumour-bearingmice
were euthanized before the large tumours could cause discomfort. The effects of non-
tumour specific inflammation on the Thy1 expression was also tested by injecting the
ears of both B6.Cg-Tg(Thy1-YFP)16Jrs/J and BALB/c(Thy1-YFP) mice with 20 ml
complete Freund’s adjuvant (Sigma, St. Louis, USA) or sterile physiological saline
solution s.c. In another series of experiments, superficial cuts were made with a sterile
scalpel blade in the ear pinnae of the mice under sodium pentobarbital (Nembutal)
anaesthesia. The wound- healing process was followed by fluorescent microscopy for
36 days.
Imaging studies. The photographs were made with a Nikon Eclipse E600 fluorescent
microscope, using the B-2A filter block (EX:450; DM . 505; BA:520). The
micrographs were made with a SPOT RT-SETM Digital Camera (Diagnostic
Instruments) or with a Nikon D5000 camera. Frozen tissue sections were analyzed by
Zeiss Axio Imager Z1 fluorescent microscope and Zeiss AxioVision 4.6.3 software.
The contrast of the micrographs was adjusted with the Adobe Photoshop software.
The same corrections were applied for the experimental samples and their
appropriate controls. The YFP fluorescence was visualized with a pseudo-green
colour.
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